Clinical Transplantation has just published a study led by Carol Holman, who is now at the University of Iowa, about the risk of PTLD in relation to the amount of Epstein-Barr virus (EBV) in the blood posttransplant.
The Journal of Experimental Medicine has just published a study led by Dare Odumade showing that primary EBV infection does not damage host responses to other viral pathogens.
Congratulations to Carol, Dare and our entire research team. It is not common to have two major research articles published in the same month!